[Automatic translation follows] Le Figaro, the culture of freedom since 1826, the leading general daily newspaper and the most visited news site in France. With an audience of over 9 million unique visitors (source: Médiamétrie/NetRatings), the site is characterized by the quality and depth of its content, the result of the complementarity between its paper editorial teams (daily and magazines) and its web editorial team; by its Internet 2.0 uses and the importance of video, which has become a central element of the content offering. Lefigaro.fr also bases its development on the synergies built with the other sites of the …

Sectors: Media

The official account of the French Government Follow Government news on this page in real time, including practical information, measures, numbers, results, and the profiles of economic players !

[Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Les Entreprises du médicament, brings together companies in the pharmaceutical industry sector in France. Created over 130 years ago, Leem now has nearly 270 member companies, which generate nearly 98% of the total turnover of pharmaceuticals in France. The pharmaceutical industry employs 100,000 people in over 150 professions, and has recruited 10,000 employees per year for the past 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in …

Sectors: Startup accelerator & VC

[Automatic translation follows] Official account of the Ministry of Health and Access to Care The Ministry of Health and Access to Care prepares and implements the Government's policy in the areas of public health, prevention and access to care. health, solidarity, public administration, poverty, care, and solidarity

[Automatic translation follows] For safe, effective, innovative and accessible health products The National Agency for the Safety of Medicines and Health Products is the public actor that allows, on behalf of the State, access to health products in France and ensures their safety throughout their life cycle. At the heart of the health system, we act in the service of patients and their safety. We promote access to innovative products via authorization procedures adapted to each stage of the life of the drug before and after it is placed on the market. Through our assessments, our expertise and our monitoring …